Sources of Medical Technology: Universities and Industry (1995)
Chapter: APPENDIX A: WORKSHOP AGENDA
Appendix A
Workshop Agenda
THE UNIVERSITY-INDUSTRY INTERFACE AND MEDICAL INNOVATION
Sunday, February 21, 1993
|
2:30 p.m. |
Welcome Kenneth Shine, President, Institute of Medicine; Introduction to the Workshop Enriqueta Bond, Executive Officer, Institute of Medicine |
|
Session I. Setting The Stage |
|
|
Moderator: |
Ken Melmon, Stanford University Some Further Thoughts on the Origin of the Workshop |
|
3:00 |
Medical Innovation and the Economic Environment Victor Fuchs, Stanford University |
|
3:30 |
R&D Management: An Academic Perspective Stanley Cohen, Stanford University |
|
4:00 |
Institutional Factors Affecting the University-Industry Interface Niels Reimers, Technology Linkages International |
|
4:30 |
Discussion |
|
5:00 |
R&D Management: An Industrial Perspective Alejandro Zaffaroni, ALZA Corporation |
|
5:30 |
The Evolution of Biotechnology Drugs at AMGEN and ICOS George Rathmann, ICOS |
|
Respondent: |
Joel Birnbaum, Hewlett-Packard |
|
6:00 |
Discussion |
|
7:00 |
Adjourn and Dinner |
Monday, February 22, 1993
|
8:15 a.m. |
Continental Breakfast |
|
Session II. Medical Device Innovation |
|
|
Moderator: |
Bill Hubbard, Former President, The Upjohn Company |
|
Respondents: |
Ben Holmes, Hewlett-Packard; James Benson, Health Industry Manufacturers Association; and Harvey Rudolph, Food and Drug Administration |
|
8:45 |
Minimally Invasive Therapy: The Case of Endoscopy Introduction: Nathan Rosenberg, Stanford University, and Annetine Gelijns, Institute of Medicine/Columbia University Discussion |
|
9:45 |
The Laser in Medicine: Birth of a New Industry Introduction: Joanne Spetz, Stanford University Discussion |
|
10:45 |
Break |
|
11:00 |
Cardiovascular Diagnostics Introduction: Stan Finkelstein, Massachusetts Institute of Technology, Gregory Bell, Charles River Associates, and Kevin Neels, Quintiles Discussion |
|
12:00 |
Medical Imaging: MRI and PET Introduction: Richard Rettig, Institute of Medicine, Holly Dawkins, Institute of Medicine, and Everette James, Vanderbilt University Discussion |
|
1:00 |
Lunch |
|
2:15 |
Cochlear Implants Introduction: Stuart Blume, University of Amsterdam Discussion |
|
Session III. Pharmaceutical And Biotech Innovation |
|
|
Moderator: |
Stanley Reiser, University of Texas Health Science Center |
|
Respondents: |
Gerald Laubach, Former President, Pfizer; Rebecca Henderson, Massachusetts Institute of Technology; James Benson, Health Industry Manufacturers Association |
|
3:15 |
Purine Metabolism and the Development of Chemotherapeutic Agents Introduction: Chris Flowers and Ken Melmon, Stanford University Discussion |
|
4:15 |
Break |
|
4:30 |
Innovation in Biotechnology: The Case of the Small Firm Introduction: Alfonso Gambardella, Bocconi University, Milan, and Ashish Arora, Carnegie-Mellon University Discussion |
|
5:30 |
Adjournment |
Tuesday, February 23, 1993
|
Session III. Pharmaceutical And Biotech Innovation (continued) |
|
|
Moderator: |
Stanley Reiser, University of Texas Health Science Center |
|
Respondents: |
Gerald Laubach, Former President, Pfizer; Rebecca Henderson, Massachusetts Institute of Technology; James Benson, Health Industry Manufacturers Association |
|
8:00 a.m. |
Innovation in Compounds to Treat Diabetes Introduction: Scott Stern, Stanford University Discussion |
|
9:00 |
What Is Public? What Is Private? And What Should Be? Richard Nelson, Columbia University Discussion |
|
9:30 |
General Discussion |
|
10:00 |
Break |
|
10:30 |
Where Do We Go From Here? Ken Melmon, Stanford University Richard Nelson, Columbia University Nathan Rosenberg, Stanford University |
|
11:00 |
Adjournment |
